Leslie Tari - 27 Mar 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: CHIEF SCIENTIFIC OFFICER
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 29 Mar 2023, 17:26:42 UTC
Previous filing: 13 Mar 2023
Next filing: 14 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+90,000	+47%	$0.000000	280,179	27 Mar 2023	Direct	F1
holding	CDTX	Common Stock						1,484	27 Mar 2023	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+180,000		$0.000000	180,000	27 Mar 2023	Common Stock	180,000	$1.01	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.